MYOM2 and AL amyloidosis: In this study, after treatment, the improvement degree of M protein and myeloma levels in the combined group is better than that in the control group, indicating that the combined treatment of elderly multiple myeloma can more effectively improve the body's immunity and inhibit the proliferation of myeloma cells.